X-Pure na imprensa
The potential of gelatin to optimize cell line development workflows
European Biopharmaceutical Review October 2022, pages 68-70. © Samedan Ltd.Optimal gelatin-base biomaterial
Medical Device development, 2022, Vol 1Biomaterials: Challenges, Characteristics, and Considerations
European Biopharmaceutical Review, January 2022, pages 70-72. © Samedan LtdEndotoxins – The Unwanted Contaminants in Biomaterials for Regenerative Medicines
European Biopharmaceutical Review, April 2021, pages 32 – 33. © Samedan Ltd- A View from the Bench
European Biopharmaceutical Review, July 2019
- Rousselot to Showcase Gelatins Porfolio at CPhI 2018
Pharmtech.com, September 2018
- Rousselot leads on innovation at CPhI with state-of-the-art gelatins
Manufacturing Chemist, August 2018